ATHENEX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ATHENEX and buy or sell other stocks, ETFs, and their options commission-free!About ATNXQ
Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments.
CEOYiu Nam Lau, MD
CEOYiu Nam Lau, MD
Employees—
Employees—
HeadquartersBuffalo, New York
HeadquartersBuffalo, New York
Founded2003
Founded2003
Employees—
Employees—
ATNXQ Key Statistics
Market cap131.70K
Market cap131.70K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.93K
Average volume1.93K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.00
52 Week high$6.00
52 Week low$0.0003
52 Week low$0.0003
Stock Snapshot
As of today, ATHENEX(ATNXQ) shares are valued at $0.02. The company's market cap stands at 131.7K.
On 2025-12-09, ATHENEX(ATNXQ) stock opened at —, reached a high of —, and a low of —.
The ATHENEX(ATNXQ)'s current trading volume is 0, compared to an average daily volume of 1.93K.
In the last year, ATHENEX(ATNXQ) shares hit a 52-week high of $6.00 and a 52-week low of $0.00.
In the last year, ATHENEX(ATNXQ) shares hit a 52-week high of $6.00 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own ATNXQ. This list is generated using Robinhood data, and it’s not a recommendation.